Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Characteristics, interventions and longer-term outcomes of COVID-19 ICU patients in Denmark - a nationwide, observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Philipp Schuetz
  • Albertus Beishuizen
  • Michael Broyles
  • Ricard Ferrer
  • Gaetan Gavazzi
  • Eric Howard Gluck
  • Juan González Del Castillo
  • Peter Laszlo Kanizsai
  • Andrea Lay Hoon Kwa
  • Stefan Krueger
  • Charles-Edouard Luyt
  • Michael Oppert
  • Mario Plebani
  • Sergey A Shlyapnikov
  • Giulio Toccafondi
  • Jennifer Townsend
  • Tobias Welte
  • Kordo Saeed
  • Jens Ulrik Stæhr Jensen
Vis graf over relationer

Background Procalcitonin (PCT)-guided antibiotic stewardship (ABS) has been shown to reduce antibiotics (ABxs), with lower side-effects and an improvement in clinical outcomes. The aim of this experts workshop was to derive a PCT algorithm ABS for easier implementation into clinical routine across different clinical settings. Methods Clinical evidence and practical experience with PCT-guided ABS was analyzed and discussed, with a focus on optimal PCT use in the clinical context and increased adherence to PCT protocols. Using a Delphi process, the experts group reached consensus on different PCT algorithms based on clinical severity of the patient and probability of bacterial infection. Results The group agreed that there is strong evidence that PCT-guided ABS supports individual decisions on initiation and duration of ABx treatment in patients with acute respiratory infections and sepsis from any source, thereby reducing overall ABx exposure and associated side effects, and improving clinical outcomes. To simplify practical application, the expert group refined the established PCT algorithms by incorporating severity of illness and probability of bacterial infection and reducing the fixed cut-offs to only one for mild to moderate and one for severe disease (0.25 μg/L and 0.5 μg/L, respectively). Further, guidance on interpretation of PCT results to initiate, withhold or discontinue ABx treatment was included. Conclusions A combination of clinical patient assessment with PCT levels in well-defined ABS algorithms, in context with continuous education and regular feedback to all ABS stakeholders, has the potential to improve the diagnostic and therapeutic management of patients suspected of bacterial infection, thereby improving ABS effectiveness.

OriginalsprogEngelsk
TidsskriftClinical Chemistry and Laboratory Medicine
Vol/bind57
Udgave nummer9
Sider (fra-til)1308-1318
Antal sider11
ISSN1434-6621
DOI
StatusUdgivet - 27 aug. 2019

ID: 61232979